Skip to search formSkip to main contentSkip to account menu

AM-0715

Known as: AM 0715, AM 715, AM0715 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Norfloxacin (NFLX, AM-715), a new quinolone antibiotic agent, was evaluated clinically and bacteriologically for its efficacy and… 
Highly Cited
1983
Highly Cited
1983
The mechanisms of the renal excretion of AM-715, a synthetic antimicrobial agent, were studied in rabbits, dogs, and humans. In… 
Highly Cited
1983
Highly Cited
1983
A comparison was made of the in vitro activities of norfloxacin and of nine other orally administered antibacterial agents… 
1983
1983
Norfloxacin is a new orally absorbed quinoline derivative structurally related to nalidixic acid but showing an expanded… 
1983
1983
1. Ito, A., Hirai, K., Inoue, M., Koga, H., Suzue, S., Irikura, T., Mitsuhashi, S.: In vitro antibacterial activity of AM-715, a… 
1981
1981
Dose for dose, AM-715 was at least five times as active as pipemidic acid and nalidixic acid against systemic and urinary bladder… 
1981
1981
The in vitro activity of a new ora antimicrobial agent, Mk-0366 (AM-715), was compared with those of rosoxacin, ampicillin… 
Highly Cited
1980
Highly Cited
1980
AM-715 [1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid] is a new nalidixic acid analog. AM-715…